Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea ...Middle East

"Expected to change GERD drug market landscape" Application for product approval of Fexuclue, a new drug for gastroesophageal reflux disease (GERD), has been completely submitted to Colombia, Vietnam, and Saudi Arabia NDA submissions in 11 countries completed in the shortest time among...

Hence then, the article about daewoong pharmaceutical submitted nda for its global new drug fexuclue in 11 countries only 1 year after approval in korea was published today ( Thursday 26/01/2023 - 04:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea )

Also on site :

• My Big Family Once Formed the Backbone of My Life. Then, We Discovered My Sister’s Horrific Actions. Now Nothing Is the Same.
• HomeGoods' Gorgeous New Valentine's Glassware Has Shoppers Saying: 'I Need It All'
• ‘Beloved’ Woodford Reserve Bourbon Is Back Nationwide